Tumor necrosis factor-α induces pial arteriolar dilation in newborn pigs

Brain Research Bulletin

Volumn 39, Issue 4, 1996, Pages 241-247

  Shibata, Masaaki ^a   Parfenova, Helena ^c   Zuckerman, Samuel L ^c   Leffler, Charles W ^b  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c NONE

Author keywords

Cerebrovascular; Cytokines; Endothelial derived relaxing factor; Prostaglandins

Indexed keywords

AMINOGUANIDINE; CYCLIC AMP; CYCLIC GMP; ENDOTHELIUM DERIVED RELAXING FACTOR; INDOMETACIN; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN SYNTHASE; PROSTANOID; TUMOR NECROSIS FACTOR ALPHA;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; ENZYME ACTIVITY; HYPOTHESIS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; SWINE; VASODILATATION;

EID: 0029670490     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/0361-9230(95)02142-6     Document Type: Article

References (51)

1. Armstead, W. M. Role of nitric oxide and cAMP in prostaglandin-induced pial arterial dilation. Am. J. Physiol. 268:H1436-H1440; 1995.
2. Armstead, W. M.; Zuckerman, S. L.; Shibata, M.; Parfenova, H.; Leffler, C. W. Different pial arteriolar responses to acetylcholine in the newborn and juvenile pig. J. Cereb. Blood Flow Metab. 14:1088-1095; 1994.
3. Beasley, D.; Eldridge, M. Interleukin-1b and tumor necrosis factor-a synergistically induce NO synthase in rat vascular smooth muscle cells. Am. J. Physiol. 266:R1197-R1203; 1994.
4. Benveniste, E. N. Inflammatory cytokines within the central nervous system: Sources, function, and mechanism of action. Am. J. Physiol. 263:C1-C16; 1992.
5. Beutler, B. Endotoxin, tumor necrosis factor, and related mediators: New approaches to shock. New Horizons 1:3-12; 1993.
6. Boje, K. M.; Arora, P. K. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res. 587:250-256; 1992.
7. Chavanet, P. C.; Bonnotte, B.; Guiguet, M.; Zeller, V.; Solary, E.; Maurice, L.; Cassanovas, O.; Caillot, D.; Waldner, A.; Kisterman, J. P.; Portier, H. High concentrations of intrathecal interleukin-6 in human bacterial and nonbacterial meningitis. J. Infect. Dis. 166:428-431; 1992.
8. 2 activity and synthesis of a phospholipase A2-activating protein in endothelial cells. Biochem. J. 250:125-132; 1988.
9. Dinarello, C. A.; Bernheim, H. A. Ability of human leukocytic pyrogen to stimulate brain prostaglandin synthesis in vitro. J. Neurochem. 37:702-708; 1981.
10. Durieu-Trautmann, O.; Federici, C.; Creminon, C.; Foignant-Chaverot, N.; Roux, F.; Claire, M.; Strosberg, A. D.; Couraud, P. O. Nitric oxide and endothelin secretion by brain microvessel endothelial cells: regulation by cyclic nucleotides. J. Cell. Physiol. 155:104-111; 1993.
11. Eckly, A. E.; Lugnier, C. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway. Br. J. Pharmacol. 113:445-450; 1994.
12. Griffith, M. J. D.; Messent, M.; MacAllister, R. J.; Evans, T. W. Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br. J. Pharmacol. 110:963-968; 1993.
13. Gross, S. S.; Jaffe, E. A.; Levi, R.; Kilbourn, R. G. Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogs with a rank-order of potency characteristic of activated macrophages. Biochem. Biophys. Res. Commun. 178:823-829; 1991.
14. Halstensen, A.; Ceska, M.; Brandzaeg, P.; Redl, H.; Naess, A.; Waage, A. Interleukin-8 in serum and cerebrospinal fluid from patients with meningococcal disease. J. Infect. Dis. 167:471-475; 1993.
15. Henry, Y.; Lepoivre, M.; Drapier, J.-C.; Ducrocq, C.; Boucher, J.-L.; Guissani, A. EPR characterization of molecular targets for NO in mammalian cells and organelles. FASEB J. 7:1124-1134; 1993.
16. Ignarro, L. J.; Buga, G. M.; Wood, K.; Byrn, R. Endothelium-derived factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. USA 84:9265-9269; 1987.
17. 2 production by vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 194:420-424; 1993.
18. Koide, M.; Kawahara, Y.; Tsuda, T.; Yokoyama, M. Cytokine-induced expression of an inducible type of nitric oxide synthase gene in cultured vascular smooth muscle cells. FEBS Lett. 318:213-217; 1993.
19. Lamas, S.; Michel, T.; Brenner, B. M.; Marsden, P. A. Nitric oxide synthesis in endothelial cells: Evidence for a pathway inducible by TNF-a. Am. J. Physiol. 261:C634-C641; 1991.
20. Laszlo, F.; Evans, S. M.; Whittle, B. J. R. Aminoguanidine inhibits both constitutive and inducible nitric oxide synthase isoforms in rat intestinal microvasculature in vivo. Eur. J. Pharmacol. 272:169-175; 1995.
21. Leffler, C. W.; Busija, D. W. Arachidonate metabolism on the cerebral surface of newborn pigs. Prostaglandins 30:811-818; 1985.
22. Megyeri, P.; Abraham, C. S.; Temesvari, P.; Kovacs, J.; Vas, T.; Speer, C. P. Recombinant human tumor necrosis factor a constricts pial arterioles and increases blood-brain barrier permeability in newborn piglets. Neurosci. Lett. 148:137-140: 1992.
23. Misko, T. P.; Moore, W. M.; Kasten, T. P.; Nickols, G. A.; Corbett, J. A.; Tilton, R. G.; McDaniel, M. L.; Williamson, J. R.; Currie, M. G. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur. J. Pharmacol. 233:119-125; 1993.
24. ++-calmodulin-independent NO-synthase. Biochem. Biophys. Res. Commun. 191:327-334; 1993.
25. Moncada, S. The L-arginine:nitric oxide pathway. Acta Physiol. Scand. 145:201-227; 1992.
26. Morin, A. M.; Stanboli, S. Nitric oxide synthase in cultured endothelial cells of cerebrovascular origin: cytochemistry. J, Neurosci. Res. 36:272-279; 1993.
27. Mustafa, M. M.; Ramilo, O.; Olsen, K.; Franklin, P. S.; Hansen, E. J.; Beutler, B.; McCracken, G. H., Jr. Tumor necrosis factor in mediating experimental Haemophilus influenzae type B meningitis. J. Clin. Invest. 84:1253-1259; 1989.
28. Palmer, R. M. J.; Ferrige, A. G.; Moncada, S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524-526; 1987.
29. Parfenova, H.; Shibata, M.; Zuckerman, S. L.; Leffler, C. W. Cyclic nucleotides and cerebrovascular tone in newborn pigs. Am. J. Physiol. 265:H1972-H1982; 1993.
30. 2 and cerebral circulation in newborn pigs: Cyclic nucleotides and prostanoids in vascular regulation. Am. J. Physiol. 266:H1494-H1501; 1994.
31. 2 inhibits cerebrovascular changes and brain edema formation in the tumor necrosis factor-α-independent early phase of experimental pneumococcal meningitis. J. Exp. Med. 176:265-268: 1992.
32. Pfister, H.-W.; Koedel, U.; Haberl, R. L.; Dirnagl, U.; Feiden, W.; Ruckdeschel, G.; Einhaupl, K. M. Microvascular changes during the early phase of experimental bacterial meningitis. J. Cereb. Blood Flow Metab. 10:914-922; 1990.
33. Pober, J. S.; Slowik, M. R.; De Luca, L. G.; Ritchie, A. J. Elevated cAMP inhibits endothelial cell synthesis and expression of TNF-induced endothelial leukocyte adhesion molecule-1, and vascular cell adhesion molecule, but not intercellular adhesion molecule-1. J. Immunol. 150:5114-5124; 1993.
34. Ramilo, O.; Saex-Llorens, X.; Mertsola, J.; Jafari, H.; Olsen, K. D.; Hansen, E. J.; Yoshinaga, M.; Ohkawara, S.; Nariuchi, H.; Mc-Cracken, Jr., G. H. Tumor necrosis factor-α/cachectin and interleu-kin 1β initiate meningeal inflammation. J. Exp. Med. 172:497-507: 1990.
35. Saez-Llorens, X.; Jafari, H. S.; Severien, C.; Parras, F.; Olsen, K. D.; Hansen, E. J.; Singer, I. I.; McCracken, G. H. Enhanced attenuation of meningial inflammation and brain edema by concomitant administration of anti-CD18 monoclonal antibodies and dexamethasone in experimental Haemophilus meningitis. J. Clin. Invest. 88:2003-2011; 1991.
36. Salvemini, D.; Misko, T. P.; Masferrer, J. L.; Seibert, K.; Currie, M. G.; Needleman, P. Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. USA 90:7240-7244; 1993.
37. Salvemini, D.; Seibert, K.; Masferrer, J. L.; Misko, T. P.; Currie, M. G.; Needleman, P. Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation. J. Clin. Invest. 93:1940-1947; 1994.
38. Saukkonen, K.; Sande, S.; Cioffe, C.; Wolpe, S.; Sherry, B.; Cerami, A.; Tuomanen, E. The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis. J. Exp. Med. 171:439-448; 1990.
39. Schmidt, H. H. H. W.; Lohmann, S. M.; Walter, U. The nitric oxide and cGMP signal transduction system: Regulation and mechanism of action. Biochim. Biophys. Acta 1178:153-175; 1993.
40. Scott, I. M.; Fertel, R. H.; Boulant, J. A. Leukocytic pyrogen effects on prostaglandins in hypothalamic tissue slices. Am. J. Physiol. 253:R71-R76; 1987.
41. Sharief, M. K.; Ciardi, M.; Thompson, E. J. Blood-brain barrier damage in patients with bacterial meningitis: Association with tumor necrosis factor-a but not interleukin-1β. J. Infect. Dis. 166:350-358; 1992.
42. Shibano, T.; Vanhoutte, P. M. Induction of NO production by TNF-α and lipopolysaccharide in porcine coronary arteries without endothelium. Am. J. Physiol. 264:H403-H407; 1993.
43. Shibata, M.; Leffler, C.; Busija, D. Recombinant human interleukin-1α dilates pial arterioles and increases cerebrospinal fluid prostanoids in piglets. Am. J. Physiol. 259:H1486-H1491; 1990.
44. Shibata, M.; Mirro, R.; Armstead, W. M.; Leffler, C. W. Actinomycin D blocks interleukin-1α-induced pial arteriolar dilation and increased prostanoid production in newborn pigs. Brain Res. Bull. 33:403-409; 1994.
45. Spinas, G. A.; Keller, U.; Brockhaus, M. Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia. J. Clin. Invest. 90:533-536; 1992.
46. Tureen, J. Effect of recombinant human tumor necrosis factor-alpha on cerebral oxygen uptake, cerebrospinal fluid lactate, and cerebral blood flow in the rabbit: Role of nitric oxide. J. Clin. Invest. 95:1086-1091; 1995.
47. Tureen, J. H.; Tauber, M. G.; Sande, M. A. Effect of indomethacin on the pathophysiology of experimental meningitis in rabbits. J. Infect. Dis. 163:647-649; 1991.
48. Vigne, P.; Damais, C.; Frelin, C. IL 1 and TNFα induce cGMP formation in C6 astrocytoma cells via the nitridergic pathway. Brain Res. 606:332-334; 1993.
49. Waage, A.; Halstensen, A.; Shalaby, R.; Bramdtzaeg, P.; Kierulf, P.; Espevik, T. Local production of tumor necrosis factor-α, interleukin 1, and interleukin 6 in meningococcal meningitis. J. Exp. Med. 170:1859-1867; 1989.
50. Warner, S. J. C.; Libby, P. Human vascular smooth muscle cells: Target for and source of tumor necrosis factor. J. Immunol. 142:100-109; 1989.
51. Yoshida, K.; Okamura, T.; Kimura, H.; Bredt, D. S.; Snyder, S. H.; Toda, N. Nitric oxide synthase-immunoreactive nerve fibers in dog cerebral and peripheral arteries. Brain Res. 629:67-72; 1993.